-
PDF
- Split View
-
Views
-
Cite
Cite
Helena J Teede, Marie L Misso, Michael F Costello, Anuja Dokras, Joop Laven, Lisa Moran, Terhi Piltonen, Robert J Norman, International PCOS Network, Erratum. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome, Human Reproduction, Volume 34, Issue 2, February 2019, Page 388, https://doi.org/10.1093/humrep/dey363
Close - Share Icon Share
Hum Reprod 2018;33:1602–1618
The journal, Human Reproduction, would like to apologise for an error under the sub-section Biochemical hyperandrogenism of Table III in the above article. The following statement:
Where assessment of biochemical hyperandrogenism is important in women on hormonal contraception, drug withdrawal is recommended for months or longer before measurement, and contraception management with a non-hormonal alternative is needed during this time.
Should read:
Where assessment of biochemical hyperandrogenism is important in women on hormonal contraception, drug withdrawal is recommended for 3 months or longer before measurement, and contraception management with a non-hormonal alternative is needed during this time.
The electronic version of this article has been updated at https://doi.org/10.1093/humrep/dey256. The Journal would like to assure readers that this does not affect any other content of the article.
